Profile | GDS4284 / 222934_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 622.234 | 67 |
GSM687648 | Patient 402 control | 1077.16 | 75 |
GSM687653 | Patient 403 control | 493.316 | 64 |
GSM687658 | Patient 404 control | 3466.26 | 90 |
GSM687663 | Patient 411 control | 1932.89 | 84 |
GSM687668 | Patient 422 control | 1236.59 | 77 |
GSM687673 | Patient 424 control | 1063.71 | 75 |
GSM687678 | Patient 425 control | 1456.08 | 79 |
GSM687683 | Patient 427 control | 1142.58 | 75 |
GSM687688 | Patient 428 control | 316.981 | 57 |
GSM687695 | Patient 441 control | 7216.09 | 96 |
GSM687699 | Patient 443 control | 3064.94 | 89 |
GSM687704 | Patient 444 control | 578.803 | 66 |
GSM687707 | Patient 448 control | 646.166 | 67 |
GSM687712 | Patient 449 control | 1070.48 | 75 |
GSM687719 | Patient 450 control | 1790.29 | 83 |
GSM687724 | Patient 451 control | 437.404 | 61 |
GSM687728 | Patient 452 control | 6059.71 | 95 |
GSM687646 | Patient 401 treated 24h | 422.657 | 60 |
GSM687649 | Patient 402 treated 24h | 1207.49 | 76 |
GSM687665 | Patient 411 treated 24h | 1625.61 | 81 |
GSM687651 | Patient 402 treated 4 weeks | 1125.23 | 75 |
GSM687667 | Patient 411 treated 4 weeks | 722.403 | 69 |
GSM687670 | Patient 422 treated 24h | 937.865 | 72 |
GSM687671 | Patient 422 treated 4 weeks | 983.338 | 73 |
GSM687654 | Patient 403 treated 24h | 773.632 | 70 |
GSM687675 | Patient 424 treated 24h | 1382.83 | 79 |
GSM687685 | Patient 427 treated 24h | 1955.38 | 84 |
GSM687656 | Patient 403 treated 4 weeks | 268.449 | 55 |
GSM687677 | Patient 424 treated 4 weeks | 752.338 | 69 |
GSM687687 | Patient 427 treated 4 weeks | 361.944 | 59 |
GSM687692 | Patient 428 treated 4h | 521.127 | 64 |
GSM687716 | Patient 449 treated 4h | 302.56 | 57 |
GSM687722 | Patient 450 treated 4h | 957.829 | 73 |
GSM687680 | Patient 425 treated 24h | 1412.63 | 79 |
GSM687690 | Patient 428 treated 24h | 488.721 | 64 |
GSM687700 | Patient 443 treated 24h | 7102.28 | 96 |
GSM687705 | Patient 444 treated 24h | 1030.03 | 75 |
GSM687714 | Patient 449 treated 24h | 1142.74 | 76 |
GSM687721 | Patient 450 treated 24h | 3586.13 | 91 |
GSM687682 | Patient 425 treated 4 weeks | 1353.9 | 78 |
GSM687694 | Patient 428 treated 4 weeks | 666.871 | 68 |
GSM687702 | Patient 443 treated 4 weeks | 1847.88 | 83 |
GSM687718 | Patient 449 treated 4 weeks | 618.106 | 67 |
GSM687723 | Patient 450 treated 4 weeks | 701.879 | 69 |
GSM687661 | Patient 404 treated 4h | 3813.69 | 91 |
GSM687710 | Patient 448 treated 4h | 400.448 | 61 |
GSM687726 | Patient 451 treated 4h | 257.736 | 51 |
GSM687730 | Patient 452 treated 4h | 1362.87 | 79 |
GSM687660 | Patient 404 treated 24h | 48649.6 | 99 |
GSM687697 | Patient 441 treated 24h | 10185.1 | 97 |
GSM687709 | Patient 448 treated 24h | 971.147 | 74 |
GSM687725 | Patient 451 treated 24h | 1054.23 | 75 |
GSM687729 | Patient 452 treated 24h | 10449.5 | 97 |
GSM687727 | Patient 451 treated 4 weeks | 446.496 | 61 |
GSM687731 | Patient 452 treated 4 weeks | 3919.14 | 91 |